ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATRC AtriCure Inc

22.42
-0.16 (-0.71%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 305,333
Bid Price 22.00
Ask Price 22.78
News -
Day High 22.935

Low
20.19

52 Week Range

High
59.61

Day Low 22.0315
Company Name Stock Ticker Symbol Market Type
AtriCure Inc ATRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.16 -0.71% 22.42 20:00:00
Open Price Low Price High Price Close Price Prev Close
22.22 22.0315 22.935 22.42 22.58
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,485 305,333 $ 22.59 $ 6,897,056 - 20.19 - 59.61
Last Trade Time Type Quantity Stock Price Currency
16:21:00 average 1,050 $ 22.42 USD

AtriCure Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.07B 47.59M - 399.25M -30.44M -0.64 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AtriCure News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATRC Message Board. Create One! See More Posts on ATRC Message Board See More Message Board Posts

Historical ATRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.3923.5521.860422.46606,2890.030.13%
1 Month22.0424.0221.2622.47616,1400.381.72%
3 Months32.2632.6220.1924.62753,683-9.84-30.50%
6 Months32.9839.04520.1929.32668,877-10.56-32.02%
1 Year48.5659.6120.1934.40523,627-26.14-53.83%
3 Years74.8589.1820.1944.49355,859-52.43-70.05%
5 Years29.6989.1820.1944.59352,368-7.27-24.49%

AtriCure Description

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.